The U.S. health regulator has issued a warning to Intas Pharmaceuticals, citing manufacturing lapses, including breaches…
Tag: Quality Assurance
Schedule M to be compulsory for MSME firms involved in drug manufacturing: Govt
New Delhi: The Centre will make ‘Schedule M’ compulsory for medium, small, and micro enterprises (MSMEs)…
A Harvard Branch in India, Prospects and Challenges
It would be worthwhile to look at the experience of other countries for positive and negative…